ArticleBMJ open2026
Association of COVID-19 public health measures with cardiac non-invasive testing utilisation in Ontario, Canada: a population-based, retrospective time series analysis.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe COVID-19 pandemic disrupted healthcare delivery worldwide, beginning in early 2020. While cardiac non-invasive testing (NIT) plays a critical role in the evaluation and management of cardiovascular disease, the population-level association of pandemic-related public health measures on cardiac diagnostics remains unclear.
objectiveTo compare the rates and patterns of cardiac NIT before and after the implementation of the first and subsequent provincial COVID-19 lockdown measures. DESIGN AND
settingA population-based and registry-based retrospective time series analysis conducted in Ontario, Canada, a single-payer healthcare system.
participantsAll individuals receiving transthoracic echocardiography, stress echocardiography, nuclear imaging, cardiac CT or cardiac MRI between 17 March 2018 and 16 March 2022. OUTCOME MEASURES: Standardised weekly testing rates compared across pre-pandemic and pandemic intervals using ARIMA (autoregressive integrative moving average) modelling.
resultsAmong 5 269 897 cardiac tests performed, the cumulative rates decreased from 228.8 (95% CI 228.5 to 229.0) tests per 100 000 person-weeks in the pre-pandemic period to 204.3 (95% CI 204.0 to 204.5) tests per 100 000 person-weeks in the pandemic period (p<0.0001). The first lockdown led to the most significant decrease in cumulative testing rate (105.9 per 100 000 person-weeks, 95% CI 105.4 to 106.4, p<0.0001), with an incomplete recovery over time that varied based partially on NIT modality. Outpatient testing decreased more compared with inpatient testing. The rates of transthoracic echocardiography and nuclear imaging decreased, whereas cardiac MRI remained stable and cardiac CT increased.
conclusionsDuring the COVID-19 pandemic in Ontario, cumulative cardiac NIT rates declined significantly and did not fully recover by early 2022. The magnitude and patterns of these declines raise concerns about delayed cardiovascular diagnoses while also signalling a possible shift in diagnostic strategies. Efforts should prioritise preserving access to essential diagnostic testing during future health crises.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.